KEGG: cha:CHAB381_1381
STRING: 360107.CHAB381_1381
What are the optimal storage and handling conditions for recombinant C. hominis MscL protein?
Proper storage and handling are critical for maintaining the functionality of recombinant MscL protein:
a) Storage Conditions:
b) Reconstitution Protocol:
Briefly centrifuge the vial prior to opening to bring contents to the bottom
Reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL
Add glycerol to 5-50% final concentration for long-term storage (50% is recommended)
c) Buffer Considerations:
Tris/PBS-based buffer with 6% Trehalose at pH 8.0 is suitable for storage
When using for functional studies, consider the impact of buffer components on membrane properties
d) Quality Control:
Verify protein integrity by SDS-PAGE before use
For functional studies, periodically confirm channel activity
What controls should be included when testing C. hominis MscL activity in experimental systems?
Robust experimental design requires appropriate controls:
a) Negative Controls:
Inactive MscL mutants (e.g., deletion of critical residues)
Empty vector controls for expression systems
Untransfected/untreated cells in mammalian expression systems
Wild-type bacteria without MscL for functional complementation studies
b) Positive Controls:
Well-characterized MscL variants with known activity (e.g., E. coli MscL)
Chemical activators that can trigger channel opening independently of mechanical force
Parent strains with antibiotic markers for recombination assays
c) Experimental Validation:
PCR verification of genetic constructs using locus-specific primers
Western blotting to confirm protein expression
Patch clamp recordings to directly verify channel activity
d) System-Specific Controls:
How can the purity and functionality of recombinant C. hominis MscL be verified?
Multiple approaches can verify both purity and functionality:
a) Purity Assessment:
SDS-PAGE analysis (>90% purity is generally suitable for functional studies)
Size exclusion chromatography to verify oligomeric state
Mass spectrometry to confirm protein identity and detect modifications
b) Structural Integrity:
Circular dichroism spectroscopy to assess secondary structure content
Native PAGE to verify pentameric assembly
Negative-stain electron microscopy for visual confirmation of structure
c) Functional Verification:
Patch clamp electrophysiology in reconstituted systems
Liposome swelling assays to measure channel activity
Fluorescent dye uptake in cells expressing the recombinant protein
Complementation of MscL-deficient bacterial strains
d) Practical Workflow:
Initial purity assessment by SDS-PAGE
Structural verification by size exclusion chromatography
Functional testing in an appropriate membrane system
Comparison to well-characterized MscL variants (e.g., E. coli MscL)
What are the applications of recombinant C. hominis MscL in studying bacterial pathogenesis and developing novel antimicrobials?
Recombinant C. hominis MscL has several research and therapeutic applications:
a) Understanding Bacterial Adaptation:
Study how C. hominis survives osmotic stress during colonization
Investigate the role of MscL in environmental persistence and transmission
Examine potential contributions to inflammatory bowel disease pathogenesis
b) Antimicrobial Development:
MscL represents a potential target for novel antibiotics against Campylobacter species
Compounds that inappropriately trigger MscL opening could disrupt bacterial osmotic balance
Species-specific MscL variations could enable targeted antimicrobial approaches
c) Experimental Tools:
Use as a model system for studying mechanosensation mechanisms
Development of biosensors for detecting membrane perturbations
d) Methodological Applications: